Matsui, Kunihiko https://orcid.org/0000-0002-3750-3440
Kusano, Kengo
Akao, Masaharu
Tsuji, Hikari
Hiramitsu, Shinya
Hatori, Yutaka
Odakura, Hironori
Ogawa, Hisao
Clinical trials referenced in this document:
Documents that mention this clinical trial
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy
https://doi.org/10.1038/s41598-024-65237-4
Documents that mention this clinical trial
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy
https://doi.org/10.1038/s41598-024-65237-4
Article History
Received: 9 January 2024
Accepted: 18 June 2024
First Online: 22 June 2024
Competing interests
: All authors have completed the ICMJE uniform disclosure and declare the following: Kengo Kusano received honoraria for educational lectures from Medtronic, Bayer, Bristol-Myers Squibb, and Daiichi-Sankyo and research grants from Medtronic, EPI, and Boston Scientific. Masaharu Akao received research funding from Bayer Yakuhin, scholarship funds from Bayer Yakuhin and Daiichi-Sankyo, and lecture fees from Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim, Bayer Yakuhin, and Daiichi-Sankyo. Shinya Hisamitsu received honoraria for educational lectures from Bayer. All other authors (Kunihiko Matsui, Hikari Tsuji, Yutaka Hatori, Hironori Odakura, and Hisao Ogawa) have no financial interests to declare.